← Open Payments lookup

MARK WAYNIK: Open Payments

NPI 1588738256 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,940 in 365 payments from 20 companies in 2025. Trend: 2023 $7,207 · 2024 $7,564 · 2025 $7,940

Food & beverage: $7,940
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.32$1,037
Otsuka America Pharmaceutical, Inc.44$950
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$810
ABBVIE INC.36$773
Corium, LLC30$608
E.R. Squibb & Sons, L.L.C.42$596
Axsome Therapeutics, Inc.13$406
Alkermes, Inc.16$401
Lundbeck LLC22$396
Takeda Pharmaceuticals U.S.A., Inc.18$364

Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, Azstarys, COBENFY, Auvelity, ARISTADA.

Industry payments across CT — which companies pay providers there.